Satellos Bioscience MSLE
NASDAQ MSLE
$6.77 -0.23 (-3.28%)
As of: Oct 21, 2026 · 3:41 PM EDT

Satellos Bioscience (MSLE) Total Non-Current Liabilities (2024 - 2026)

Updated

Analysis

Satellos Bioscience (MSLE) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn 106.45 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn 97.04 Bn
10 Satellos Bioscience 98.81 Mn -109.33 Mn - -13.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.46 Mn
Mar 31, 2026 -14.76 Mn
Dec 31, 2025 -11.38 Mn
Dec 31, 2024 -15.66 Mn
API Access

Satellos Bioscience Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MSLE&period=max&api_key=YOUR_API_KEY